Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Balance Sheet

Financials in millions NZD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	21.06	7.99	11.52	9.54	6.17
Short-Term Investments	6.08	14.16	18.7	36.39	51.24
Cash & Short-Term Investments	27.14	22.15	30.23	45.93	57.4
Cash Growth	22.52%	-26.72%	-34.20%	-19.98%	55.29%
Accounts Receivable	39.23	32.28	26.28	22.72	15.13
Other Receivables	1.39	1.78	2.61	3.02	2.04
Receivables	40.63	34.06	28.89	25.74	17.17
Inventory	6.02	8.27	8.1	4.83	3.98
Prepaid Expenses	3.5	2.41	1.82	1.44	1.33
Other Current Assets	-	-	-	0.19	-
Total Current Assets	77.28	66.88	69.04	78.14	79.88
Property, Plant & Equipment	20.71	21.51	22.22	20.64	15.36
Goodwill	5.54	5.54	5.54	5.54	5.54
Other Intangible Assets	7.89	9.11	10.11	10.75	11.73
Long-Term Accounts Receivable	3.18	1.3	-	-	-
Long-Term Deferred Charges	5.98	4.46	4.05	1.33	-
Other Long-Term Assets	0.06	0.08	0.1	0.13	0.15
Total Assets	120.64	108.87	111.06	116.52	112.65

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	5.86	2.93	1.71	1.91	1.33
Accrued Expenses	5.78	3.61	5.74	5.44	4.69
Current Portion of Leases	1.48	1.12	1	0.56	0.59
Current Income Taxes Payable	-	-	-	-	0.05
Current Unearned Revenue	1.29	-	-	-	-
Other Current Liabilities	1.8	2.64	1.06	0.01	0.05
Total Current Liabilities	16.21	10.3	9.51	7.91	6.71
Long-Term Leases	4.9	5.3	6.43	6.55	5.29
Other Long-Term Liabilities	0.2	0.19	0.17	0.17	0.16
Total Liabilities	21.31	15.79	16.12	14.63	12.16

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	147.11	146.84	146.8	146.49	145.76
Retained Earnings	-53.81	-64.06	-62.15	-51.52	-51.13
Comprehensive Income & Other	6.04	10.3	10.29	6.92	5.86
Shareholders' Equity	99.34	93.09	94.94	101.89	100.49
Total Liabilities & Equity	120.64	108.87	111.06	116.52	112.65

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	6.38	6.42	7.44	7.11	5.88
Net Cash (Debt)	20.76	15.73	22.79	38.83	51.53
Net Cash Growth	31.95%	-30.96%	-41.30%	-24.65%	148.56%
Net Cash Per Share	0.06	0.05	0.07	0.11	0.15
Filing Date Shares Outstanding	345.48	344.9	344.21	343.11	342.46
Total Common Shares Outstanding	345.48	344.9	344.21	343.11	342.46
Working Capital	61.07	56.58	59.52	70.22	73.17
Book Value Per Share	0.29	0.27	0.28	0.30	0.29
Tangible Book Value	85.91	78.43	79.29	85.6	83.22
Tangible Book Value Per Share	0.25	0.23	0.23	0.25	0.24
Machinery	15.21	14.55	12.6	11.93	10.48
Construction In Progress	8.34	8.41	8.32	5.73	4.17
Leasehold Improvements	5.6	5.08	4.88	4.62	1.63

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 6, 2026

Data Sources Report a data error